State-Sponsored Racism: FDA Guidelines Instruct Healthcare Providers to Prioritize Racial Minorities Over Whites For Access to Scarce Covid Treatments
In several states like New York, Minnesota, Utah, and even Texas, non-white citizens are receiving priority for scarce monoclonal antibody treatments and Covid oral antiviral pills, regardless of their age or underlying conditions, thanks to Marxist health-equity policies that have been implemented by the local governments.
This ‘rationing based on race’ policy has sparked intense backlash against the states which have implemented them, but the idea did not start within local health departments – the destructive scheme actually came directly from the Food and Drug Administration (FDA), according to the agency’s own documents.
The FDA’s emergency use authorizations for monoclonal antibodies and oral antivirals specify that the treatments have only been authorized for “high risk” patients.
